| Name | Title | Contact Details |
|---|---|---|
Tejasree Pagidipati |
Chief Information Security Officer | Profile |
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.
Emmis Interactive is a Chicago, IL-based company in the Software and Internet sector.
One DLP Technologies is a Sunnyvale, CA-based company in the Software and Internet sector.
Generate revenue, not just leads. Drive a more predictable pipeline. metadata.io is a demand generation platform for B2B marketers that need to generate pipeline and revenue.
Avanquest Software is one of the world's leading developers and publishers of business and consumer software for the global computer market.